Volume 19 Issue 8
Aug.  2021
Turn off MathJax
Article Contents
LIN Ni, KE Qu-qing, JIANG Ling-yan, OU Lan-zhi, LIU Die-mei, WU Yu-yan, DU Qing-feng. The clinical application value of homocysteine[J]. Chinese Journal of General Practice, 2021, 19(8): 1358-1361. doi: 10.16766/j.cnki.issn.1674-4152.002060
Citation: LIN Ni, KE Qu-qing, JIANG Ling-yan, OU Lan-zhi, LIU Die-mei, WU Yu-yan, DU Qing-feng. The clinical application value of homocysteine[J]. Chinese Journal of General Practice, 2021, 19(8): 1358-1361. doi: 10.16766/j.cnki.issn.1674-4152.002060

The clinical application value of homocysteine

doi: 10.16766/j.cnki.issn.1674-4152.002060
Funds:

 2020YFC2006401

  • Received Date: 2020-12-21
    Available Online: 2022-02-16
  • Homocysteine (Hcy) is produced in the process of essential amino acid methionine to cysteine conversion, and participates in DNA metabolism through methylation. In recent years, many studies have shown that serum Hcy levels were directly or indirectly related to various diseases, such as arteriosclerosis, cardiovascular disease, hypertension, neurological disease, diabetes, cancer, pregnancy disease, eye disease and osteoporosis. The normal range of Hcy in human plasma is 5-15 μmol/L, and >15 μmol/L is hyper homocysteine (HHcy). Gene mutations, malnutrition caused by folic acid, vitamin B6, and B12 deficiency, and a high-methionine diet are common causes of elevated Hcy. Studies have confirmed that the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism is associated with the susceptibility to elevated plasma Hcy levels, and the expression of the MTHFR 677TT genotype in the Chinese population is significantly higher than that of other races. The pathogenic mechanism of increased serum Hcy levels may be: promotion of inflammation and vascular calcification, impaired lipid peroxidation and antioxidant processes, stimulation of the production of reactive oxygen species, induction of oxidative stress and vascular dysfunction, endothelial cell toxicity and dysfunction, inhibit the release of neurotransmitters, and so on. Other pathogenic mechanisms still need to be further studied. The level of Hcy is important for the risk prediction of the disease, the controlling of the disease complications and the prognosis of the disease. The overall prevalence of HHcy in Chinese population is high, and the regional differences are significant. With the increase of age, the prevalence also increases. Monitoring of Hcy is conducive to early detection and diagnosis of diseases and prevention of serious complications. To provide reference for the clinical application of Hcy, this study comprehensively explores the relationship between Hcy and disease and its pathogenic mechanism on the basis of the latest literatures.

     

  • loading
  • [1]
    徐炳欣, 赵艳, 段淑娟, 等. 亚甲基四氢叶酸还原酶a1298c基因多态性检测在高同型半胱氨酸血症治疗中的价值[J]. 中华全科医学, 2020, 18(9): 1470-1473. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202009012.htm
    [2]
    MOON H, KO H, KIM A. Hyperhomocysteinemia concurrent with metabolic syndrome is independently associated with chronic kidney disease among Community-Dwelling adults in an urban korean population. [J]. Int J Env Res Pub He, 2020, 17(18): 6810. doi: 10.3390/ijerph17186810
    [3]
    XU R, HUANG F, WANG Y, et al. Gender- and age-related differences in homocysteine concentration: A cross-sectional study of the general population of China[J]. Sci Rep-Uk, 2020, 10(1): 17401. doi: 10.1038/s41598-020-74596-7
    [4]
    LU S S, XIE J, SU C Q, et al. Plasma homocysteine levels and intracranial plaque characteristics: Association and clinical relevance in ischemic stroke[J]. Bio Med Central, 2018, 18(1): 200. doi: 10.1186%2Fs12883-018-1203-4.pdf
    [5]
    ZOU J, CHEN Z, LIANG C, et al. Trefoil factor 3, cholinesterase and homocysteine: Potential predictors for Parkinson's disease dementia and vascular parkinsonism dementia in advanced stage[J]. Aging Dis, 2018, 9(1): 51-65. doi: 10.14336/AD.2017.0416
    [6]
    SANTOTORIBIO J D, DEL V L, GARCÍA-DE L T A, et al. The diagnostic value of pleural fluid homocysteine in malignant pleural effusion[J]. PLoS One, 2019, 14(9): e0222616. http://www.researchgate.net/publication/336025378_The_diagnostic_value_of_pleural_fluid_homocysteine_in_malignant_pleural_effusion
    [7]
    CHANG Y, LI Y, GUO X, et al. The prevalence of hypertension accompanied by high homocysteine and its risk factors in a rural population: A Cross-Sectional study from northeast China[J]. Int J Env Res Pub He, 2017, 14(4): 376. doi: 10.3390/ijerph14040376
    [8]
    SUN P, WANG Q, ZHANG Y, et al. Association between homocysteine level and blood pressure traits among Tibetans: A cross-sectional study in China[J]. Medicine, 2019, 98(27): e16085. doi: 10.1097/MD.0000000000016085
    [9]
    王红, 康小琴, 谢文博, 等. 血浆同型半胱氨酸和高敏c反应蛋白水平与h型高血压患者左心室肥厚的关系[J]. 中国医药, 2019, 14(11): 1606-1609. doi: 10.3760/j.issn.1673-4777.2019.11.002
    [10]
    ZHOU F, HOU D, WANG Y, et al. Evaluation of H-type hypertension prevalence and its influence on the risk of increased carotid intima-media thickness among a high-risk stroke population in Hainan Province, China[J]. Medicine (Baltimore), 2020, 99(35): e21953. doi: 10.1097/MD.0000000000021953
    [11]
    何菁, 蒋利, 顾北音, 等. 高血压患者血浆同型半胱氨酸与血压变异的相关性[J]. 中国临床医学, 2017, 24(6): 920-923. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX201706017.htm
    [12]
    WANG W W, WANG X S, ZHANG Z R, et al. A meta-analysis of folic acid in combination with anti-Hypertension drugs in patients with hypertension and hyperhomocysteinemia[J]. Front Pharmacol, 2017, 31(8): 585. doi: 10.3389/fphar.2017.00585/pdf
    [13]
    WANG Y, JIN Y, WANG Y, et al. The effect of folic acid in patients with cardiovascular disease: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2019, 98(37): e17095. doi: 10.1097/MD.0000000000017095
    [14]
    CHRYSANT S G, CHRYSANT G S. The current status of homocysteine as a risk factor for cardiovascular disease: A mini review[J]. Expert review of cardiovascular therapy, 2018, 16(8): 559-565. doi: 10.1080/14779072.2018.1497974
    [15]
    HASAN T, ARORA R, BANSAL A K, et al. Disturbed homocysteine metabolism is associated with cancer[J]. Exp Mol Med, 2019, 51(2): 1-13. http://www.onacademic.com/detail/journal_1000041601204699_5db2.html
    [16]
    XU J, ZHAO X, SUN S, et al. Homocysteine and digestive tract cancer risk: A dose-response meta-analysis[J]. J Oncol, 2018, 2018(18): 3720684. http://www.onacademic.com/detail/journal_1000041641508099_855f.html
    [17]
    HOUGHTON S C, ELIASSEN A H, ZHANG S M, et al. Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women[J]. Breast Cancer Res Treat, 2019, 176(1): 191-203. doi: 10.1007/s10549-019-05223-x
    [18]
    李亚芹, 闫勇, 张倡誌, 等. 胃癌患者化疗前后血清β2微球蛋白、视黄醇结合蛋白、Hcy水平及T淋巴细胞亚群的变化及临床意义[J]. 癌症进展, 2019, 17(5): 585-588. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ201905024.htm
    [19]
    PLATT D E, HARIRI E, SALAMEH P, et al. Type Ⅱ diabetes mellitus and hyperhomocysteinemia: A complex interaction[J]. Diabetol Metab Syndr, 2017, 2017(9): 19. http://www.onacademic.com/detail/journal_1000039897110410_b992.html
    [20]
    MUZUROV I C ' E, KRALJEV I C ' I, SOLAK M, et al. Homocysteine and diabetes: Role in macrovascular and microvascular complications[J]. J Diabetes Complications, 2021, 35(3): 107834. doi: 10.1016/j.jdiacomp.2020.107834
    [21]
    RUJASWINI T, DEVANANDAN P, RANADHEER C P, et al. A review on association of serum homocysteine in diabetic neuropathy[J]. Drug Invention Today, 2018, 10(2): 154-156. http://www.researchgate.net/profile/Praveen_Devanandan/publication/324965481_A_review_on_association_of_serum_homocysteine_in_diabetic_neuropathy/links/5aee9f970f7e9b01d3e18cbb/A-review-on-association-of-serum-homocysteine-in-diabetic-neuropathy.pdf
    [22]
    曾金海. 同型半胱氨酸及血尿酸与2型糖尿病血管并发症的关系[J]. 中国临床新医学, 2017, 10(8): 786-788. doi: 10.3969/j.issn.1674-3806.2017.08.22
    [23]
    WANG X, ZHOU Y, ZHANG M, et al. The methylenetetrahydrofolate reductase genotype 677CT and non-alcoholic fatty liver disease have a synergistic effect on the increasing homocysteine levels in subjects from Chongqing, China[J]. Genes Dis, 2019, 6(1): 88-95. doi: 10.1016/j.gendis.2018.07.003
    [24]
    王传池, 胡镜清, 彭锦, 等. H型高血压脑卒中高发的病机探析[J]. 中国中医基础医学杂志, 2017, 23(2): 161-163. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC201702007.htm
    [25]
    GAIDAY A N, TUSSUPKALIYEV A B, BERMAGAMBETOVA S K, et al. Effect of homocysteine on pregnancy: A systematic review[J]. Chem Biol Interact, 2018, 2018(293): 70-76. http://www.researchgate.net/profile/Andrey_Gaiday2/publication/326574384_Effect_of_homocysteine_on_pregnancy_A_systematic_review/links/5b9bd8bd45851574f7cb315b/Effect-of-homocysteine-on-pregnancy-A-systematic-review.pdf
    [26]
    AZZINI E, RUGGERI S, POLITO A. Homocysteine: Its possible emerging role in At-Risk population groups[J]. Int J Mol Sci, 2020, 21(4): 1421. doi: 10.3390/ijms21041421
    [27]
    MAGED A M, SAAD H, MESHAAL H, et al. Maternal serum homocysteine and uterine artery Doppler as predictors of preeclampsia and poor placentation[J]. Arch Gynecol Obstet, 2017, 296(3): 475-482. doi: 10.1007/s00404-017-4457-y
    [28]
    SUN F, QIAN W, ZHANG C, et al. Correlation of maternal serum homocysteine in the first trimester with the development of gestational hypertension and preeclampsia[J]. Med Sci Monit, 2017, 23(11): 5396-5401. http://www.onacademic.com/detail/journal_1000040879149110_3f79.html
    [29]
    乐元芬. 胎儿生长受限孕妇妊娠晚期血清同型半胱氨酸表达水平及意义[J]. 中国妇幼保健, 2017, 32(6): 1184-1185. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201706023.htm
    [30]
    KONG X, MA X, ZHANG C, et al. Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort[J]. Int Urol Nephrol, 2017, 49(4): 661-667. doi: 10.1007/s11255-016-1452-3
    [31]
    ZHOU Y F, GUAN Y F. Hyperhomocysteinemia and kidney diseases[J]. Sheng Li Xue Bao, 2018, 70(6): 607-611. http://www.ncbi.nlm.nih.gov/pubmed/30560269
    [32]
    KUANG Z M, WANG Y, FENG S J, et al. Association between plasma homocysteine and microalbuminuria in untreated patients with essential hypertension: A case-control study[J]. Kidney Blood Press Res, 2017, 42(6): 1303-1311. doi: 10.1159/000486013
    [33]
    范斌, 李晓玉, 张萍. 老年男性血浆同型半胱氨酸水平与髋关节骨密度的相关性分析[J]. 中国医药导报, 2021, 18(3): 101-104. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202103025.htm
    [34]
    BEHERA J, BALA J, NURU M, et al. Homocysteine as a pathological biomarker for bone disease[J]. J Cell Physiol, 2017, 232(10): 2704-2709. doi: 10.1002/jcp.25693
    [35]
    OHISHI T, FUJITA T, NISHIDA T, et al. Factors influencing serum homocysteine levels in postmenopausal osteoporotic females - comparison to urinary collagen crosslinks[J]. Endocr Res, 2019, 44(3): 117-125. doi: 10.1080/07435800.2019.1577892
    [36]
    董丽娟, 高飞. 骨密度及骨代谢指标与同型半胱氨酸关系的研究进展[J]. 中国骨质疏松杂志, 2020, 26(8): 1241-1244. doi: 10.3969/j.issn.1006-7108.2020.08.031
    [37]
    LEI X, ZENG G, ZHANG Y, et al. Association between homocysteine level and the risk of diabetic retinopathy: A systematic review and meta-analysis[J]. Diabetol Metab Syndr, 2018, 2018(10): 61. http://www.onacademic.com/detail/journal_1000040484067510_990c.html
    [38]
    PINNA A, ZACCHEDDU F, BOSCIA F, et al. Homocysteine and risk of age-related macular degeneration: A systematic review and meta-analysis[J]. Acta Ophthalmol, 2018, 96(3): e269-e276. doi: 10.1111/aos.13343
    [39]
    JENKINS D, SPENCE J D, GIOVANNUCCI E L, et al. Supplemental vitamins and minerals for CVD prevention and treatment[J]. J Am Coll Cardiol, 2018, 71(22): 2570-2584. doi: 10.1016/j.jacc.2018.04.020
    [40]
    SPENCE J D. Nutrition and risk of stroke[J]. Nutrients, 2019, 11(3): 647. doi: 10.3390/nu11030647
    [41]
    SPENCE J D, YI Q, HANKEY G J. B vitamins in stroke prevention: Time to reconsider[J]. Lancet Neurol, 2017, 16(9): 750-760. doi: 10.1016/S1474-4422(17)30180-1
    [42]
    SPENCE J D, HACHINSKI V. B vitamins for stroke prevention: Interaction of low platelet count and high plasma total homocysteine[J]. J Am Coll Cardiol, 2018, 71(19): 2147-2148. doi: 10.1016/j.jacc.2018.03.024
    [43]
    LIND M V, LAURITZEN L, KRISTENSEN M, et al. Effect of folate supplementation on insulin sensitivity and type 2 diabetes: A meta-analysis of randomized controlled trials[J]. Am J Clin Nutr, 2019, 109(1): 29-42. doi: 10.1093/ajcn/nqy234
    [44]
    KAGAWA Y, HIRAOKA M, KAGEYAMA M, et al. Medical cost savings in Sakado City and worldwide achieved by preventing disease by folic acid fortification[J]. Congenit Anom (Kyoto), 2017, 57(5): 157-165. doi: 10.1111/cga.12215
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (439) PDF downloads(81) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return